Brain stimulation tech developer Neuroelectrics announced today that it’s secured FDA breakthrough device designation for its Starstim neuromodulation platform to treat refractory focal epilepsy. Starstim includes transcranial electrical stimulation (tES), personalized treatment protocols and a secure cloud-based mechanism to deliver treatment anywhere. “We are excited to receive the FDA Breakthrough Device Designation for our lead […]
neuroelectrics
Neuroelectrics raises $17.5M Series A
Brain stimulation technology developer Neuroelectrics announced today that it raised $17.5 million in a Series A financing. Morningside Ventures led the funding round, the proceeds for which are earmarked for the development of Neuroelectrics’ non-invasive transcranial electrical stimulation (tES) platform. Cambridge, Mass./Barcelona, Spain-based Neuroelectrics plans to use funds to advance clinical trials for the platform […]
Neuroelectrics touts FDA IDE Starstim epilepsy treatment study data
Medical device dev Neuroelectrics today released results from an FDA investigational device exemption trial of its Starstim device intended to treat patients with drug resistant epilepsy, touting a significant reduction in seizure frequency. The Starstim device from the Cambridge, Mass.-based company provides transcranial current stimulation, delivering mild electrical currents to the specific areas of the […]
